CNC - Centene Corporation

NYSE - NYSE Delayed Price. Currency in USD
56.04
+0.47 (+0.85%)
At close: 4:03PM EDT
Stock chart is not supported by your current browser
Previous Close55.57
Open54.81
Bid55.01 x 800
Ask56.45 x 800
Day's Range54.81 - 56.53
52 Week Range45.44 - 74.49
Volume11,398,694
Avg. Volume8,051,138
Market Cap23.162B
Beta (3Y Monthly)1.32
PE Ratio (TTM)21.51
EPS (TTM)2.61
Earnings DateJul 23, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est73.67
Trade prices are not sourced from all markets
  • Leon Cooperman's Top 5 Buys in 1st Quarter
    GuruFocus.com2 days ago

    Leon Cooperman's Top 5 Buys in 1st Quarter

    The guru's top buys include Berkshire Hathaway airline Delta

  • 6 Positions the Vanguard Health Care Fund Continues to Increase
    GuruFocus.com2 days ago

    6 Positions the Vanguard Health Care Fund Continues to Increase

    CVS Health tops the list

  • Is Centene (CNC) Stock Undervalued Right Now?
    Zacks3 days ago

    Is Centene (CNC) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • 3 Reasons Growth Investors Will Love Centene (CNC)
    Zacks3 days ago

    3 Reasons Growth Investors Will Love Centene (CNC)

    Centene (CNC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

  • PR Newswire6 days ago

    Reminder: Centene Corporation To Host Investor Meeting In NYC On June 14, 2019

    ST. LOUIS , May 13, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will host an investor meeting, including a question-and-answer session, on Friday, June 14, 2019 ...

  • Is Centene Corporation's (NYSE:CNC) Balance Sheet Strong Enough To Weather A Storm?
    Simply Wall St.8 days ago

    Is Centene Corporation's (NYSE:CNC) Balance Sheet Strong Enough To Weather A Storm?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...

  • Barrons.com9 days ago

    Anthem, Centene, and UnitedHealth Stock Are Now Buys, Citigroup Says

    Analyst Ralph Giacobbe upgraded Anthem, Centene, and UnitedHealth to Buy from Neutral, and says the selloff is overdone.

  • Value Investing Set to Shine: 5 Top-Ranked ETFs & Stocks
    Zacks9 days ago

    Value Investing Set to Shine: 5 Top-Ranked ETFs & Stocks

    Value investing seek to capitalize on inefficiencies in the market and have the potential to deliver higher returns with lower volatility compared with growth and blend counterparts.

  • Humana deal rumors brew (again) as hedge funds consider fighting mega deal
    American City Business Journals12 days ago

    Humana deal rumors brew (again) as hedge funds consider fighting mega deal

    Rumors are again rumbling around Louisville-based health care and insurance company Humana Inc. as two hedge funds mull opposing a health insurance mega-merger. Newswire service Reuters reported Monday that two hedge funds — Corvex Management LP and Sachem Head Capital Management LP — may oppose St. Louis-based Centene Corp.'s proposed $17.3 billion acquisition of Tampa, Fla.-based WellCare Health Plans Inc. Both companies are giants in the commercial and government-backed health plan industry. The report states that the hedge funds have stakes in Centene and believe that the company may be able to do more to find out if another company, such as Humana (NYSE: HUM), would be interested in acquiring Centene.

  • Insider Monkey12 days ago

    Activist Summary: Hedge Funds Are Targeting These Two Companies

    The world of activism is always…well, active. Logically. Looking at the current most interesting moves by activist hedge funds, Lion Point Capital, Corvex Management LP, and Sachem Head Capital Management LP come into the picture. Starting with Lion Point Capital that was launched four years ago by Didric Cederholm, who previously worked as an executive […]

  • Ensign Group (ENSG) Q1 Earnings Beat Estimates, Rise Y/Y
    Zacks12 days ago

    Ensign Group (ENSG) Q1 Earnings Beat Estimates, Rise Y/Y

    Ensign Group's (ENSG) first-quarter earnings increase owing to a robust revenue stream.

  • Markit12 days ago

    See what the IHS Markit Score report has to say about Centene Corp.

    Centene Corp NYSE:CNCView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for CNC with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding CNC totaled $840 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Exclusive: Hedge funds target Centene, may oppose WellCare deal-sources
    Reuters12 days ago

    Exclusive: Hedge funds target Centene, may oppose WellCare deal-sources

    The hedge funds believe that Centene may be able to do more to find out if another company such as Humana Inc would be interested in acquiring it, the sources said. The hedge funds are seeking to take advantage of the fact that Centene needs to secure approval from its shareholders for the WellCare deal, according to the sources, who asked not to be identified because the matter is confidential.

  • Exclusive: Hedge funds target Centene, may oppose WellCare deal - sources
    Reuters12 days ago

    Exclusive: Hedge funds target Centene, may oppose WellCare deal - sources

    The hedge funds believe that Centene may be able to do more to find out if another company such as Humana Inc would be interested in acquiring it, the sources said. The hedge funds are seeking to take advantage of the fact that Centene needs to secure approval from its shareholders for the WellCare deal, according to the sources, who asked not to be identified because the matter is confidential.

  • WellCare-Centene acquisition scrutinized by American Hospital Association
    American City Business Journals13 days ago

    WellCare-Centene acquisition scrutinized by American Hospital Association

    The national organization has asked the DOJ to investigate the transaction, saying it threatens to reduce competition.

  • MEDNAX (MD) Q1 Earnings Miss Estimates, Decline Y/Y
    Zacks16 days ago

    MEDNAX (MD) Q1 Earnings Miss Estimates, Decline Y/Y

    MEDNAX's (MD) first-quarter earnings disappoint with weak revenues and elevated expenses.

  • The Vanguard Health Care Fund's Top 5 Buys of the 1st Quarter
    GuruFocus.com17 days ago

    The Vanguard Health Care Fund's Top 5 Buys of the 1st Quarter

    Health care-oriented fund’s top buys include one new holding and four position boosts

  • Analysts Are Missing the Cost Control With CVS Health
    InvestorPlace17 days ago

    Analysts Are Missing the Cost Control With CVS Health

    CVS Health (NYSE:CVS) shares rose sharply after it beat earnings estimates, but the stock remains dirt cheap. The company earned $1.427 billion, $1.62 for each fully adjusted share, on revenues of $61.6 billion. It was the first quarter that included results from Aetna, the health insurance company CVS Health bought last year. Most analysts credited Aetna with the strong numbers.Source: Mike Mozart via FlickrA raise in the earnings forecast for the year, from $6.68-$6.88 per share to $6.75-$6.90 per share, also helped the shares gain nearly 4.5% in early trade on May 1.But if the company's earnings forecast is right, its price of about $57 per share is barely 8 times earnings. Its dividend of 50 cents per share will yield 3.6% to today's stock buyer.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIf the forecast is off, it's on the low side. Customer Control for CVS StockI have been pounding the table for CVS for some time so let's review.The issue here is customer control, linking payments on health services with the income from health coverage. You can't have an unlimited draw from a limited pool of funds. The only way to control costs, whether the system is run publicly or privately, is to have control over spending. * The 10 Best Stocks to Buy for May That's what CVS is bringing to Aetna customers. It owns Caremark, a pharmacy benefit manager that can steer people to cost-effective solutions. It also owns a network of Minute Clinics that can handle front-line care efficiently, using nurses, physicians' assistants and electronic health records.This is the secret of industry winners like UnitedHealth (NYSE:UNH), which dominates in employer-paid insurance, and Centene (NYSE:CNC), which is achieving dominance in Medicare. The difference is that Centene has even more control over costs through acute care clinics and links to hospitals than UNH or CVS.Such "managed care" plans can be efficient, because most of the cost of medicine today is in dealing with "chronic conditions" like hypertension and diabetes. Here patient compliance and regular check-ups are key to keeping costs down.CVS' decision to bring in insurance dollars, and manage those dollars, now makes it very different from Walgreens (NASDAQ:WBA), once its drug store doppelganger. While CVS is selling customer control, Walgreens is selling customer convenience. Other OpportunitiesThere may be more good news coming to the sector very soon.Cigna (NYSE:CI), which unlike Aetna decided to be a buyer rather than a seller, closing on pharmacy benefit manager ExpressScripts last December, is due to report May 2. Analysts expect earnings of $3.74 per share. They are hoping for $3.81. If Cigna could maintain that pace for the year, it would have a forward price-to-earnings multiple of a little over 10, based on its May 1 price of $161 per share.Here again, the goal is to same. Cigna is getting ExpressScript's ability to bargain, to create formularies, and to drive people to cost-effective, best practice solutions. It is also getting ExpressScript's drug delivery, and its ability to administer drugs directly to patients, increasing compliance on chronic conditions. The Bottom LineWhat the private sector is doing, through CVS Health, Centene, UnitedHealth and Cigna isn't a complete solution to the nation's health care cost crisis.That's one reason why CVS Health, and the rest of the industry, is fighting the concept of Medicare for All. They fear government bargaining on acute care and drug costs, which the Veterans Administration has. They first want it for themselves, and they're slowly getting it.In the end, what the industry has to fear aren't Democrats, but business customers who now see 18% of GDP going out the door, while overseas competitors pay a fraction of that cost.Dana Blankenhorn is a financial and technology journalist. He is the author of a new mystery thriller, The Reluctant Detective Finds Her Family, available now at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. As of this writing he owned no shares in companies mentioned in this article. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 10 Best Stocks to Buy for May * 5 Elephant-Sized Companies Warren Buffett Could Buy * 7 Cheap ETFs for Novice Investors Compare Brokers The post Analysts Are Missing the Cost Control With CVS Health appeared first on InvestorPlace.

  • Teladoc Health (TDOC) Surpasses Estimates in Q1 Earnings
    Zacks17 days ago

    Teladoc Health (TDOC) Surpasses Estimates in Q1 Earnings

    Teladoc's (TDOC) loss in the first quarter can be attributed to higher operating expenses than revenues.

  • Cigna (CI) Beats Q1 Earnings Estimates, Raises 2019 View
    Zacks17 days ago

    Cigna (CI) Beats Q1 Earnings Estimates, Raises 2019 View

    Cigna (CI) beats Q1 earnings estimates on revenue growth driven by the acquisition of Express Scripts.

  • Top Ranked Growth Stocks to Buy for May 2nd
    Zacks17 days ago

    Top Ranked Growth Stocks to Buy for May 2nd

    Top Ranked Growth Stocks to Buy for May 2nd

  • PR Newswire17 days ago

    Centene To Present At Two Upcoming Healthcare Conferences In May

    ST. LOUIS, Mo. , May 2, 2019 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at two healthcare conferences in May. On Wednesday, May 15 th at 8:00 a.m. Pacific Time (PT), ...

  • Humana (HUM) Q1 Earnings & Revenues Beat Estimates, SurgeY/Y
    Zacks18 days ago

    Humana (HUM) Q1 Earnings & Revenues Beat Estimates, SurgeY/Y

    Humana's (HUM) first-quarter earnings benefit from Medicare Advantage membership growth and robust revenues.

  • WellCare Health (WCG) Q1 Earnings Beat Estimates, Rise Y/Y
    Zacks18 days ago

    WellCare Health (WCG) Q1 Earnings Beat Estimates, Rise Y/Y

    WellCare Health's (WCG) first-quarter earnings gain from the acquisition of Meridian and organic growth.

  • 2020 hopeful John Hickenlooper says there won't be medicare for all right away
    Yahoo Finance Video18 days ago

    2020 hopeful John Hickenlooper says there won't be medicare for all right away

    The health care topic is near the top of the list for 2020 hopefuls - including former Colorado governor John Hickenlooper. Yahoo Finance's Rick Newman spoke with Hickenlooper about his thoughts on "medicare for all." Yahoo Finance's Akiko Fujita, Kristin Myers, Dan Roberts, and Lending Tree Chief Economist Tendayi Kapfidze.